Modification of Certain Terminology in Title 21
FDA proposes to replace gender-specific terms in 21 CFR with gender-neutral alternatives, affecting cosmetics regulations under MoCRA. No substantive changes to requirements, but labeling and compliance documents must be updated.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. All cosmetics businesses subject to FDA regulations, including indie brands, contract manufacturers, private-label makers, and importers/distributors. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective date of final rule (proposed; comment period ends July 6, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Terminology in 21 CFR (e.g., 'man' to 'person', 'women' to 'individuals') will be updated to comply with Executive Order 14168. No changes to regulatory requirements, safety standards, or compliance obligations.
Who it affects
All cosmetics businesses subject to FDA regulations, including indie brands, contract manufacturers, private-label makers, and importers/distributors.
What you must do
Review and update internal documents, labels, and compliance materials to use gender-neutral language where applicable. No immediate action needed until final rule.
Deadline
Effective date of final rule (proposed; comment period ends July 6, 2026).
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- Medical Device User Fee Amendments; Public Meeting; Request for Comments
- Sterigenics U.S., LLC; Filing of Food Additive Petition
- FTC Issues Report to Congress on Adoption Practices
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
- New Jersey bans some products with toxic PFAS chemicals. Here’s what to know - WHYY